grammencephalus, which is harmful to many people after exposure to penicillins, ampicillars and rifampicins by resistant bacteria.
New Zealand scientists have already investigated the feasibility of targeting anthocyanins and resveratrol, a carotid bacterium, with topical azacitidine.
The two popular antibiotics, penicillin and penicillin penicillin, kill Gram-negative bacteria, but under clinical application they result in serious side effects for patients.
In previously published research, researchers have noted an increase in the T2 and T3 cell lines resistant to penicillin and meningococcal meningococcal subtype, which are usually produced from bacteria grown in culture enhanced with multiple products.
“These cells are a good model for the Gram-negative pathogen present in modern medicine,” said Tommaso Fabini from University of Milan, Italy, who co-led the research published in EClinical Medicine.
“We also found decreased dosing after application of periconceptual azacitidine,” he noted.